Ranaz Corporation
TSX VENTURE : RNZ

Ranaz Corporation

December 29, 2006 09:58 ET

Ranaz Completes its Initial Public Offering

THIS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

MONTREAL, QUEBEC--(CCNMatthews - Dec. 29, 2006) - Ranaz Corporation ("Ranaz") (TSX VENTURE:RNZ), a company specialized in manufacturing and marketing protein and dietary supplements related to weight loss or obesity treatments, announced today that it has closed its initial public offering of 6,666,667 units at a price of $0.60 per unit, for gross proceeds of $4,000,000. Each unit consists of one common share (a "Common Share") of Ranaz and one-half of one Common Share purchase warrant. Each whole Common Share purchase warrant entitles the holder upon payment of an exercise price of $0.60 in cash to purchase one Common Share at any time up to 5:00 p.m. (Montreal time) on December 29, 2008. The Common Shares will trade on the TSX Venture Exchange under the symbol "RNZ" at the opening of markets today.

Versant Partners Inc. acted as agent in the offering (the "Agent"). As consideration for its services, the Agent received a cash commission of $207,958 and broker warrants to purchase 333,333 units at any time up to 5:00 p.m. (Montreal time) on June 30, 2008.

This press release does not constitute an offer to sell or the solicitation of any offer to buy nor will there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such province, state or jurisdiction.

About Ranaz Corporation

Ranaz is a company specialized in manufacturing and marketing protein and dietary supplements in relation to weight loss or obesity treatments. Its mission is to design, develop and market nutritional, protein and dietary supplements under private brands, as well as under its own corporate brands, such as "Protidiet" and "Protilife". Through its subsidiaries, Ranaz produces high-quality dietary and protein supplements. All of Ranaz's products have common features, including flavours and tastes that meet market demands, a format tailored to the market, and quick and easy preparation, as well as scientific design and rigorous manufacturing standards.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information